DELAYED FIXED-TIME PULSATILE RELEASE DOSAGE FORMS Russian patent published in 2012 - IPC A61K9/24 A61K9/28 A61K31/519 

Abstract RU 2452472 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: present invention refers to medicine and describes a pharmaceutical composition for the delayed release of an active substance, consisting of: a core containing at least one active substance and at least one disintegrating substance; a sealing coating surrounding the core substantially consisting of at least one polymer; an external coating surrounding the sealing coating and substantially consisting of at least one hydrophilic polymer; with: at least one disintegrating substance found in the amount of 0.5-20 wt %, and at least one active substance found in the amount of 1-80 wt % in relation to the core; the sealing coating making 0.1-10 wt % in relation to the core; the external coating making 5-500 wt % in relation to the core, and wherein water solubility of the polymers found in the sealing coating and in the external covering is pH-independent.

EFFECT: given invention provides the agent release so that the agent is accessible for absorption in the release region exactly after the preset period of time.

23 cl, 7 tbl, 6 dwg, 4 ex

Similar patents RU2452472C2

Title Year Author Number
TABLET WITH ENTEROSOLUBLE COATING AND METHOD OF PREPARING 1998
  • Ullakh Ismat
  • Uilej Gehri Dzh.
RU2201217C2
PROLONGED-RELEASE ORAL PHARMACEUTICAL MEDICINAL FORM 1998
  • Karekhill' Per-Gunnar
  • Lundberg Per Jokhan
RU2214232C2
PHARMACOLOGICAL COMPOSITION WITH SWELLING COATING 2004
  • Srinivas Irukulla
  • Diksit Akhilesh Ashok
  • Reddi Pallempalli Venkata Siva
  • Reddi Billa Pravin
  • Mokhan Mehjlatur Sivaraman
  • Ravinder Kodipjaka
  • Nasare Vidzhej
  • Pergament Ehduard
RU2375048C2
CHRONOTHERAPEUTIC PHARMACEUTICAL COMPOSITION 2010
  • Boldkhane Sandzhaj
  • Jatkhar Skhripad
  • Nerurkar Manish
RU2571067C2
NEW CONTROLLED-RELEASE GRANULES AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH GRANULES 1995
  • Lars Stubberud
  • Khans Arvidsson
RU2141822C1
COMPOSITION FOR TREATING DISTURBED INNERVATION (VERSIONS) 2013
  • Fazylov Marat Feliksovich
RU2536269C1
PHARMACEUTICAL MEDICINAL FORM, RESISTANT TO GASTRIC JUICE ACTIVITY, WHICH INCLUDES N-(2-(2-PHTHALIMIDOETOXY)ACETYL)-L-ALANYL-D-GLUTAMIC ACID (LK 423) 2005
  • Bogataj Marija
  • Mrkhar Ales
  • Lavrits Anton
  • Tserne Manitsa
  • Tibaut Doris
  • Stalts Anton
  • Urleb Uros
  • Mateovits Tat'Jana
  • Tsof Greta
  • Kerk Janez
  • Dreu Rok
  • Joneda Fumio
  • Muraoka Shizuko
RU2375047C2
MEDICINAL CONTROLLED-RELEASING FORMS OF AZITHROMYCIN 1995
  • Uill'Jam Dzh.Kuratolo
  • Khilar L.Fridman
  • Richard V.Korsmejer
  • Stiven R.Le Mott
RU2130311C1
PHARMACEUTICAL COMPOSITIONS CONTAINING S1P RECEPTOR MODULATOR 2007
  • Ambjul' Mikhaehl'
  • Bejer Jutta
  • Karreno-Gomes Begona
  • R'Jugger Kollin
  • Valazza Stiven
RU2487703C2
DRUG DELIVERY SYSTEMS CONTAINING WEAKLY ALKALINE SELECTIVE 5-HT SEROTONINE ANTAGONIST AND ORGANIC ACIDS 2007
  • Venkatesh Gopi M.
  • Lai Dzin-Vang
  • Vias Nekhal Kh.
RU2490012C2

RU 2 452 472 C2

Authors

Cherea Matteo

De Luidzhi Bruski Stefano

Katstsaniga Andrea

Sangalli Marija Ehdvidzhe

Dzema Luchia

Dates

2012-06-10Published

2008-03-12Filed